within Pharmacolibrary.Drugs.ATC.D;

model D07AB19
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 3.666666666666667e-06,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 12.0,            
    Vdp             = 0.0019,
    k12             = 0.12,
    k21             = 0.12
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07AB19</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs. It is used as an anti-inflammatory and immunosuppressant in conditions such as allergies, asthma, rheumatoid arthritis, severe COVID-19, various cancers, and cerebral edema. Dexamethasone is approved and widely used both in hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Spoorenberg, SM, et al., &amp; van de Garde, EM (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. <i>British journal of clinical pharmacology</i> 78(1) 78–83. DOI:<a href=&quot;https://doi.org/10.1111/bcp.12295&quot;>10.1111/bcp.12295</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24400953/&quot;>https://pubmed.ncbi.nlm.nih.gov/24400953</a></p></li><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=&quot;https://doi.org/10.1111/cts.12724&quot;>10.1111/cts.12724</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31808984/&quot;>https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07AB19;
